The highest dose of retatrutide beat Ozempic on measures of blood sugar and weight loss, but was also associated with higher side effect rates and treatment discontinuations.

Benefit in primary prevention tracked statin intensity rather than drug class. Evolocumab added to a statin conferred further benefit over that statin, whereas EPA and fibrates did not, and …

Eli Lilly has added another arrow to the quiver of new diabetes and obesity drug retatrutide, outperforming Novo's Ozempic in a head-to-head trial.

Oct 28 (Reuters) - Eli Lilly's experimental next-generation drug retatrutide outperformed a lower-dose version of Novo Nordisk's Ozempic on blood sugar control and showed more than double weight …

Lilly's triple-G retatrutide beats Novo's Ozempic on A1C in a Ph3 head-to-head diabetes trial, with twice the weight loss.

Heart drug combo reduces kidney damage in septic shock surgery, major trial finds | !

A simple adjustment to drugs given during operations for septic shock could prevent thousands of patients suffering kidney damage, according to a major trial.